The relationship between the concentration of the proangiogenic factor VEGF, pro-inflammatory cytokine IL-6, their correlation, and the objective response to treatment (by the degree of regression), which evaluated the direct effect of neoadjuvant therapy in patients with IBC, was determined. The gene discussed is IL6; the disease is inflammatory breast carcinoma.